Skip to Main Content

Author Details

Zhuo Chen
The First Hospital of Lanzhou University
2002
44
19
PMIDPaper TitleJournal TitlePublished Year
36845133The immune-metabolic crosstalk between CD3<sup>+</sup>C1q<sup>+</sup>TAM and CD8<sup>+</sup>T cells associated with relapse-free survival in HCC.Front Immunol2023
37760912Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis.Biomedicines2023
35571053A Novel Risk Model Based on Autophagy-Related LncRNAs Predicts Prognosis and Indicates Immune Infiltration Landscape of Patients With Cutaneous Melanoma.Front Genet2022
34745985HPV-Related Promoter Methylation-Based Gene Signature Predicts Clinical Prognosis of Patients With Cervical Cancer.Front Oncol2021
31269236Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.Int J Cancer2020
32831653CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression.Cancer Cell Int2020
32857771Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis.PLoS One2020
32389504Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib.Clin Lung Cancer2020
31083486Outcome Definition Influences the Relationship Between Genetic Polymorphisms of <i>ERCC1</i>, <i>ERCC2</i>, <i>SLC22A2</i> and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients.Genes (Basel)2019
31665182Correction: Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma.PLoS One2019
31355511Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.Mol Carcinog2019
28892201Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.Mol Carcinog2018
30429608Sensitive tumour detection and classification using plasma cell-free DNA methylomes.Nature2018
29715275Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma.PLoS One2018
26822871Polymorphisms of the FOXF1 and MHC locus genes in individuals undergoing esophageal acid reflux assessments.Dis Esophagus2017
28088657Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival.Cancer Epidemiol2017
28427211Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome.Oncotarget2017
28448657Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.JAMA Oncol2017
29050231A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.Oncotarget2017
27827316BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.Clin Cancer Res2017
26816351ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients.Cancer Epidemiol2016
27487558BRM polymorphisms, pancreatic cancer risk and survival.Int J Cancer2016
27179112Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.Clin Cancer Res2016
26686201A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI⿯9041).Invest New Drugs2016
26903362Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.J Thorac Oncol2016
27028852A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer.Oncotarget2016
25826681Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.PLoS One2015
26670362Relationship between Caffeine and Levels of DNA Repair and Oxidative Stress in Women with and without a BRCA1 Mutation.J Nutrigenet Nutrigenomics2015
23645447A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).Invest New Drugs2014
24519853Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.Cancer Med2014
24679952A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).Lung Cancer2014
23322154Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk.Carcinogenesis2013
24349265Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis.PLoS One2013
23868004A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503).Br J Cancer2013
23399854Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment.Lab Invest2013
22237259Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer.J Thorac Oncol2012
22539604Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.Cancer Epidemiol Biomarkers Prev2012
21478907Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk.Oncogene2011
20063075Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriers.Cancer Causes Control2010
20498407Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma.J Clin Oncol2010
18632822Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.J Nucl Med2008
17213827DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers.Br J Cancer2007
17704253Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.J Nucl Med2007
11754636Identification of radiation-responsive genes in vitro using a gene trap strategy predicts for modulation of expression by radiation in vivo.Radiat Res2002
  • 1 - 44 of 44

Recommended Authors

Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 2
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 1
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 11
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 1
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 9
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 1
Francesca M Buffa
University of Oxford
Career Start Year 1998
Number of shared co-authors 3
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 5
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 7
Qingyi Wei
South China University of Technology
Career Start Year 1992
Number of shared co-authors 2
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 1
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 2
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 1
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 6
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 3
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 15

Collaborators

Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 30
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 19
Dangxiao Cheng
University Health Network
Co-authored papers 18
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 14
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 10
Gail Darling
University of Toronto
Co-authored papers 9
Abul Kalam Azad
University of Dhaka
Co-authored papers 7
Osvaldo Espin-Garcia
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Rayjean J Hung
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 7
Jennifer Teichman
University of Toronto
Co-authored papers 6
Lorin Dodbiba
McMaster University
Co-authored papers 6
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Maryam Mirshams
Princess Margaret Cancer Centre
Co-authored papers 5
Yonathan Brhane
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 5
Lawson Eng
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 5
Robert G Bristow
University of Toronto
Co-authored papers 5
Henry Thai
Princess Margaret Cancer Centre
Co-authored papers 4
Xin Qiu
SLR Consulting (Canada) Ltd
Co-authored papers 4
Joerg Schwock
University of Toronto
Co-authored papers 4
Laurie Ailles
University of Toronto
Co-authored papers 4
David P Goldstein
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 4
Sandy D Der
Toronto General Research Institute, University Health Network
Co-authored papers 4
Hala Girgis
Toronto General Hospital
Co-authored papers 4
Andrew Fleet
University of Toronto
Co-authored papers 4
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 3
Hala El-Zimaity
University Health Network, Princess Margaret Hospital, Toronto General Hospital
Co-authored papers 2
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 2
Gordon Fehringer
Inc. San Carlos
Co-authored papers 2
Lucia Kim
Inha University Hospital
Co-authored papers 2
Bruce C Carleton
BC Children's Hospital Research Institute
Co-authored papers 2
Release 1.2